Skip to main content
. 2020 Jul 6;2020(7):CD005583. doi: 10.1002/14651858.CD005583.pub3

Comparison 2. H. pylori eradication vs control ‐ subgroup analysis according to presence or absence of pre‐neoplastic lesions at baseline.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
2.1 Incidence of gastric cancer according to presence or absence of pre‐neoplastic lesions at baseline 7 8307 Risk Ratio (M‐H, Random, 95% CI) 0.64 [0.43, 0.96]
2.1.1 Patients with precancerous lesions 4 3425 Risk Ratio (M‐H, Random, 95% CI) 0.86 [0.47, 1.59]
2.1.2 Patients without precancerous lesions 2 1812 Risk Ratio (M‐H, Random, 95% CI) 0.42 [0.02, 7.69]
2.1.3 Mixed patients with and without precancerous lesions or ulcer (can't separate) 3 3070 Risk Ratio (M‐H, Random, 95% CI) 0.42 [0.22, 0.78]